References
- Reilly F D, Russell P T. Neurohistochemical evidence supporting an absence of adrenergie and cholinergic innervation in the human placenta and umbilical cord. Anat Rec 1977; 188: 277–86
- Bjøro K, Stray-Pedersen S. In vitro perfusion studies on human umbilical arteries. I, Vasoactive effects of serotonin, PGF2α, and PGE2. Acta Obstet Gynecol Scand 1986; 65: 351–5
- Haugen G, Bjøro K, Stray-Pedersen S. Vasoactive effects of intravascular and extravaseular serotonin, PGE2 and PGF2α in human umbilical arteries. Gynecol Obstet Invest 1991; 31: 208–12
- Altura B M, Malaviya D, Reich C F, Orkin L R. Effects of vasoactive agents on isolated human umbilical arteries and veins. Am J Physiol 1972; 222: 345–55
- Tuvemo T. Role of prostaglandins, prostacyclin, and thromboxanes in the control of the umbilicalplacental circulation. Semin Perinatol 1980; 4: 91–5
- Furchgott R F, Zawadzki J V. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 1980; 288: 373–6
- De Mey J G, Vanhoutte P M. Heterogeneous behaviour of the canine arterial and venous wall. Circ Res 1982; 51: 439–47
- Vane J R, Änggård E E, Botting R M. Regulatory functions of the vascular endothelium. New Eng J Med 1990; 323: 27–36
- Reidy M A, Schwartz S M. Endothelial regeneration. III. Time course of intimal changes after small defined injury to rat aortic endothelium. Lab Invest 1981; 44: 301–8
- Gebrane-Younes J, Hoang Ngoc Minh, Orcel L. Ultrastrueture of human umbilical vessels: A possible role in amniotic fluid formation?. Placenta 1986; 7: 173–85
- Bjøro K, Hovig T, Stokke K T, Stray-Pedersen S. Formation of prostanoids in human umbilical vessels perfused in vitro. Prostaglandins 1986; 31: 683–98
- Haegerstrand A, Hemsén A, Gillis C, Larsson O, Lundberg J M. Endothelin: presence in human umbilical vessels, high levels in fetal blood and potent constrictor effect. Acta Physiol Scand 1989; 137: 541–2
- Van de Voorde J, Vanderstichele H, Leusen I. Release of endothelium-derived relaxing factor from human umbilical vessels. Circ Res 1987; 60: 517–22
- Gude N M, King R G, Brennecke S P. Role of endothelium-derived nitric oxide in maintenance of low fetal vascular resistance in placenta. Lancet 1990; ii: 1589–90
- Myatt L, Brewer A, Brockman D E. The action of nitric oxide in the perfused human fetal-placental circulation. Am J Obstet Gynecol 1991; 164: 687–92
- Pinto A, Sorrentino R, Sorrentino P, Guerritore T, Miranda L, Biondi A, Martinelli P. Endothelialderived relaxing factor released by endothelial cells of human umbilical vessels and its impairment in pregnancy-induced hypertension. Am J Obstet Gynecol 1991; 164: 507–13
- Ignarro L J, Kadowitz P J. The pharmacological and physiological role of cyclic GMP in vascular smooth muscle relaxation. Ann Rev Pharmacol Toxicol 1985; 25: 171–91
- Taylor S G, Weston A H. Endothelium-derived hyperpolarizing factor: a new endogenous inhibitor from the vascular endothelium. Trends Pharmacol Sci 1988; 9: 272–4
- Davies P F, Olesen S-P, Clapham D E, Morrel E M, Schoen F J. Endothelial communication. Hypertension 1988; 11: 563–72
- Bjøro K, Stray-Pedersen S. Characterization of the responses to serotonin and prostanoids in human umbilical arteries perfused in vitro. Scand J Clin Lab Invest 1986; 46: 85–90
- Bjøro K. Prostacyclin and thromboxane formation in human umbilical arteries following stimulation with vasoactive autacoids. Prostaglandins 1986; 31: 699–714
- Haugen G, Bjøro K, Stray-Pedersen S. The influence of extra-umbilical serotonin, PGE2 and PGF2α on prostanoid production in human umbilical arteries. Scand j Clin Lab Invest 1991; 51: 131–5
- McGrath J C, Templeton A, Whittle M J. The lack of influence on the endothelium on responses to 5-HT and oxygen in the human umbilical cord blood vessels. Br J Pharmacol 1988; 95: 687P
- Martin W. Basal release of endothelium-derived relaxing factor. Relaxing and Contracting Factors, P M Vanhoutte. Humana Press, Clifton, NJUSA 1988; 159–78